Sona Nanotech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Investments
  • 2

Sona Nanotech General Information

Description

Developer of biocompatible gold nanorods designed for cancer therapies and diagnostic testing. The company's patented synthesis process eliminates cytotoxic surfactants and enables tunable resonance, providing the medical and scientific markets with functionalized nanoparticles for photothermal therapy, drug delivery, and enhanced immunoassay sensitivity.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Purdy's Wharf Tower II, 1969 Upper Water Street
  • Suite 2001
  • Halifax, Nova Scotia B3J 3R7
  • Canada
+1 (902)
Primary Industry
Drug Delivery
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • Purdy's Wharf Tower II, 1969 Upper Water Street
  • Suite 2001
  • Halifax, Nova Scotia B3J 3R7
  • Canada
+1 (902)

Sona Nanotech Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sona Nanotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sona Nanotech‘s full profile, request access.

Request a free trial

Sona Nanotech Patents

Sona Nanotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025260166-A1 Combination therapies and methods and uses thereof for treating cancer Pending 19-Jun-2024
WO-2025217727-A1 Conjugate compounds, methods of making same, and methods and uses thereof Pending 16-Apr-2024
US-20240295558-A1 Metal nanoparticles and method of making same Pending 04-Nov-2017
AU-2018360637-A1 Metal nanoparticles and methods of making same Inactive 04-Nov-2017
CA-3079759-A1 Metal nanoparticles and methods of making same Active 04-Nov-2017 G01N33/575
To view Sona Nanotech’s complete patent history, request access »

Sona Nanotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sona Nanotech‘s full profile, request access.

Request a free trial

Sona Nanotech Acquisitions (2)

Sona Nanotech’s most recent deal was a Merger/Acquisition with Siva Therapeutics for . The deal was made on 23-Mar-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Siva Therapeutics 23-Mar-2023 Merger/Acquisition Therapeutic Devices
Stockport Exploration 08-Aug-2018 Merger/Acquisition Energy Exploration
To view Sona Nanotech’s complete acquisitions history, request access »

Sona Nanotech FAQs

  • When was Sona Nanotech founded?

    Sona Nanotech was founded in 2013.

  • Where is Sona Nanotech headquartered?

    Sona Nanotech is headquartered in Halifax, Canada.

  • What industry is Sona Nanotech in?

    Sona Nanotech’s primary industry is Drug Delivery.

  • Is Sona Nanotech a private or public company?

    Sona Nanotech is a Public company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process